Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001493152-24-049670
Filing Date
2024-12-12
Accepted
2024-12-12 06:13:09
Documents
98

Document Format Files

Seq Description Document Type Size
1 forms-1.htm   iXBRL S-1 6205130
2 ex5-1.htm EX-5.1 10747
3 ex23-1.htm EX-23.1 4254
4 CALCULATION OF FILING FEE TABLES ex107.htm EX-FILING FEES 16082
5 ex5-1_001.jpg GRAPHIC 5391
  Complete submission text file 0001493152-24-049670.txt   24852693

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cldi-20240930.xsd EX-101.SCH 141272
7 XBRL CALCULATION FILE cldi-20240930_cal.xml EX-101.CAL 114637
8 XBRL DEFINITION FILE cldi-20240930_def.xml EX-101.DEF 732872
9 XBRL LABEL FILE cldi-20240930_lab.xml EX-101.LAB 1048244
10 XBRL PRESENTATION FILE cldi-20240930_pre.xml EX-101.PRE 834392
101 EXTRACTED XBRL INSTANCE DOCUMENT forms-1_htm.xml XML 4342237
Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Filer) CIK: 0001855485 (see all company filings)

EIN.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-283741 | Film No.: 241543158
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)